Qiming Venture Partners announced on Tuesday the final closing of its RMB-denominated Fund VI at 2.852 billion yuan ($440.3 million) as the China-based venture capital (VC) major ups its stake in early- and-growth-stage healthcare and TMT startups.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
